Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

December 03, 2014

NEW YORK—A United States government program meant to reward pharmaceutical companies for investing in research and development (R&D) for neglected diseases, and which will soon include Ebola on its list of eligible diseases, is enriching drug companies without ensuring that patients, treatment providers, or governments have access to these lifesaving drugs at an affordable price, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) Monday.

November 18, 2014

“The pharmaceutical industry-supported Tufts Center for the Study of Drug Development claims it costs US$2.56 billion to develop a new drug today; but if you believe that, you probably also believe the earth is flat.

“GlaxoSmithKline’s CEO Andrew Witty himself says the figure of a billion dollars to develop a drug is a myth; this is used by the industry to justify exorbitant prices. We need to ask ourselves, if the CEO of a top pharmaceutical company says it’s a myth that it costs a billion dollars to develop a drug, can we really take this new figure 2.56 billion seriously?

September 26, 2014

As Indian prime minister Narendra Modi makes his first official visit to the US, MSF is urging the Indian government to resist US pressure to drop the use of public health safeguards in its intellectual property laws.

May 19, 2014

Phumeza Tisile, co-author of the DR-TB Manifesto and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide.

April 09, 2014

 

Geneva/New York—Patent barriers and high prices on oral treatments for hepatitis C could make it too expensive for developing countries to scale-up diagnosis and treatment of the disease, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today. The warning comes as the World Health Organization (WHO) issued the first-ever guidelines for treatment of hepatitis C virus (HCV). 

March 06, 2014

Boston/New York, March 6, 2014—Two new studies released today by Epicentre,the research arm of the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at CROI, the Conference on Retroviruses and Opportunistic Infections, point to reductions in new HIV infections in areas where HIV treatment has been greatly expanded. The studies are some of the first to look at large-scale antiretroviral therapy (ART) rollout in real-world high-HIV-burden settings in sub-Saharan Africa, and its possible impact on reducing new infections.

February 20, 2014

Despite minimal concessions, US demands remain extremely dangerous to all patients’ health across the Asia-Pacific region.

January 21, 2014

JOHANNESBURG/NEWYORK, JANUARY 21, 2014—The international medical humanitarian organization Doctor Without Borders/Médecins Sans Frontières (MSF) is urging the South African government to continue to stand strong against a broad, multinational pharmaceutical industry effort to undermine and delay the efforts to reform patent laws and improve access to affordable medicines.

January 21, 2014

JOHANNESBURG/NEWYORK, JANUARY 21, 2014—The international medical humanitarian organization Doctor Without Borders/Médecins Sans Frontières (MSF) is urging the South African government to continue to stand strong against a broad, multinational pharmaceutical industry effort to undermine and delay the efforts to reform patent laws and improve access to affordable medicines.

July 23, 2012

Starved for Attention nominated in the "New Approaches to Documentary Programming" Category.

Pages